Watkins tells IndieWire about the "incredibly supportive atmosphere" that allowed him to make an R-rated horror movie that just happens to exist in a comic book universe.
The 'Obsession' director accepted IndieWire's Future of Filmmaking Award at our Los Angeles summit, where he discussed his whirlwind year and his advice for young directors.
Exclusive: AFM will offer badge holders access to the operating system to enable filmmakers to more easily connect with buyers, financiers, and sales agents.
Stewart will continue to host the show on Monday nights, with a rotating cast of correspondents handling the rest of the week, for the remainder of Trump's second term.
The director and composer look back on their exploitation classic as Delia prepares to perform the score live at a 45th-anniversary screening at the Southampton Playhouse.
Co-director Lance Oppenheim takes IndieWire inside the extremely unusual way his collaboration with Nathan Fielder and Elizabeth Holmes documentary came together.
After less than three years at the streamer, Lin is the latest high-powered exec to exit Netflix as it reorganizes its org chart and cuts around 1,000 jobs in the process.
Composer Lukas Frank called Tony Gilroy's version of the “Behemoth!" original song “Your God Is Sleeping” a "’70s protest song." “It wasn't that lame,” joked the director at the
Marie Kreutzer's "Gentle Monster" is yet another example of how Seydoux explores the dark side of the human psyche. It could land her an Oscar nomination.
Producer Nina Jacobson also revealed why "Crazy Rich Asians" is getting an HBO series instead of a movie sequel at IndieWire's Future of Filmmaking Summit.
Joined by Moore, the star of his latest film “The Debut,” filmmaker Jesse Eisenberg revealed to the Middleburg Film Festival audience that every scene used is his leads' "first
Paramount's new "Street Fighter" reboot is generating as much hype for its eclectic cast as its IP. Its box-office success might be a case study in marketing through WTF casting.
Nathan Fielder and Lance Oppeheim's look at the Theranos founder appears to be resonating with audiences as it looks at a $7 million to $8 million opening.